PropertyValue
?:definition
  • Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (e.g., serum, urine) to determine the fatty-acid-binding protein (FABP), sometimes named heart FABP. The level of liberated FABP increases, both in blood and in urine, soon after the occurrence of heart damage (e.g., as the result of myocardial infarction or cardiac surgery) and before the increase of creatine kinase activity, permitting its use as an early and specific cardiac marker.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3690887_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3690887_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all